What is RVMD's five-year median P/S?

72.9x. Half of RVMD's weekly readings since August 2022 were higher and half were lower. This page has 221 weekly readings, from Aug 8, 2022 to Oct 26, 2026.

Does a low historical rank mean a stock is a buy?

No. The rank compares RVMD only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.

Revolution Medicines Inc (RVMD) P/S ratio history

Health Care

$188.72

Latest weekly close · Market cap $39.8B

Revolution Medicines' P/S is unavailable because recent financial data is missing (as of Oct 29, 2026).

No P/E: earnings over the last twelve months are negative.
No EV/Sales: recent financial data is missing.
No EV/EBITDA: recent financial data is missing.

No P/S chart for RVMD right now

P/S

n/mnot ranked

No P/S rank: recent financial data is missing.

Growth, last 12 months vs the year before

Revenue: n/m
EPS: n/m

Price vs revenue and EPS, indexed to 100

Each line starts at 100 at its first positive reading over the last five years. Revenue and EPS change at fiscal quarter ends. EPS was not positive in this window, so it is left out.

PriceRevenue, last 12 months100 = first reading

P/S at each year-end

The last weekly reading of each year, and its percentile against the five years before it.

RVMD P/S at each year-end
Year-end	P/S	5-year percentile
Dec 29, 2025	n/m	Too little history
Dec 30, 2024	n/m	Too little history
Dec 25, 2023	119.7×	97
Dec 26, 2022	68.4×	Too little history

Health Care peers on P/S

Each percentile compares a stock with its own last five years.

Compare RVMD with peers

Health Care peers of RVMD on P/S
Stock	P/S	Versus its own history	5-year percentile
ABBVAbbVie	7.9×	Historically high	100
AMGNAmgen	6.5×	Historically high	99
ARWRArrowhead Pharmaceuticals Inc	12.9×	Within its usual range	37
BBIOBridgebio Pharma Inc	19.4×	Below its usual range	19
BIIBBiogen	3.5×	Above its usual range	73

Appears in

Sector: Health Care
Screens: Nuclear Stocks: Valuation Screen
Semiconductor Equipment Stocks: Valuation Screen

Screen Health Care stocks the same way

Research on RVMD

No articles about RVMD yet. How valuation percentiles work

Loading peers and related research…

About this history

What is RVMD's current P/S?: Revolution Medicines' P/S is unavailable because recent financial data is missing (as of Oct 29, 2026).
What is RVMD's five-year median P/S?: 72.9x. Half of RVMD's weekly readings since August 2022 were higher and half were lower. This page has 221 weekly readings, from Aug 8, 2022 to Oct 26, 2026.
Does a low historical rank mean a stock is a buy?: No. The rank compares RVMD only with its own past. Slower growth or more risk can justify a lower multiple than before. P/E uses earnings and P/S uses revenue from the last twelve months.